We showed that suppressing this gene reduced the spread of cancer by more than 80%.
Our next goal was to then find a way to suppress Bcl3 pharmacologically. Despite great improvements in therapy of early stage breast cancer, the current therapeutic options for patients with late stage metastatic disease are limited.
There is therefore a clear unmet clinical need to identify new drugs to reverse or at least to slow down disease progression.
More top news
A former solider is helping to combat loneliness with a cafe where former military personnel can find the friendship and support they need.
French president Emmanuel Macron called on Donald Trump to launch a new era of 21st century leadership and security.
Charity Divert is working with the Metropolitan Police Service (MPS) to stop reoffending by intervening at the point of detention.